Chiraharit Ltd opened its Initial Public Offering (IPO) on September 30, 2025. The bidding window for the Chiraharit IPO was open till October 3, 2025, and the allotment process for the IPO is expected to be finalised today, on October 6, 2025.
Chiraharit Ltd is a provider of innovative solutions across various sectors, with a focus on sustainability and quality. The company's shares will be listed on the BSE, with a tentative listing date set for October 8, 2025.
Here is the process to check the Chiraharit IPO Allotment on the BSE:
[October 3, 2025, end of the day]
On day 3, Chiraharit IPO was subscribed 1.88 times. The public issue was subscribed to 3.03 times in the individual investors category, 0 times in QIB, and 0.73 times in the NII category.
The Chiraharit IPO was a fixed-price issue of ₹31.07 crores. The issue is entirely a fresh issue of 1.48 crore shares. The IPO price band was set at ₹21 per share. The minimum lot size for an application was 6000. The minimum amount of investment required by an individual investor (retail) was ₹2,52,000 (12,000 shares) based on the upper price.
Finshore Management Services Ltd. was the book running lead manager, and Bigshare Services Pvt.Ltd was the registrar of the issue. The Market Maker of the company was Anant Securities.
Chiraharit Limited, part of the Malaxmi Group and headquartered in Hyderabad, specialises in turnkey EPC solutions for water and renewable energy sectors. Its offerings include pressurised irrigation systems, drinking water infrastructure, solar module cleaning systems, and Compressed Bio-Gas (CBG) plants. The company caters to a range of projects, including agricultural, industrial, and residential, across India.
In FY25, Chiraharit reported a revenue of ₹59.80 crore, up from ₹30.57 crore in FY24. Profit after tax increased to ₹6.02 crore, compared to ₹0.60 crore in FY24. EBITDA stood at ₹9.93 crore, with an EBITDA margin of 16.36%. The return on net worth was 62.91%, reflecting a strong financial performance.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here.